Trial Profile

RAPID EC - Randomized Controlled Trial Assessing Pregnancy With Intrauterine Devices for Emergency Contraception

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 01 Jul 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Levonorgestrel (Primary) ; Levonorgestrel (Primary) ; Copper
Indications Pregnancy
Focus Therapeutic Use

Most Recent Events

01 Jul 2021 Results of secondary analysis assessing pregnancy risk after intrauterine device (IUD) placement by the number and timing of unprotected intercourse episodes in the prior 14 days published in the Obstetrics and Gynecology
12 Jun 2021 Results of secondary analysis, quantifying sexual intercourse practices and backup contraception use following levonorgestrel IUS or CuT380A IUD placement and to calculate the risk of pregnancy in users who resume intercourse within one week of device placement, published in the Contraception
25 Apr 2021 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com